UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

CPR Decision Aid For Patients With Advanced Gynecologic Malignancies

Not Applicable

Completed

Conditions: Advance Care Planning

Interventions: Behavioral: video
Behavioral: usual care

First Posted Date: 2017-08-16

Last Posted Date: 2019-08-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT03251976

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

VX-770 for the Treatment of Chronic Bronchitis

Phase 4

Withdrawn

Conditions: Chronic Bronchitis

Interventions: Drug: Ivacaftor (VX-770)

First Posted Date: 2017-08-16

Last Posted Date: 2022-02-17

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03251911

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)

Completed

Conditions: De-escalation
Decision Making ,Shared

Interventions: Other: Qualitative Interview or Focus group discussions

First Posted Date: 2017-08-14

Last Posted Date: 2023-01-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 200

Registration Number: NCT03248258

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

Phase 4

Completed

Conditions: Postpartum Fever
Postpartum Sepsis
Postpartum Endometritis

Interventions: Drug: Azithromycin and amoxicillin
Drug: Azithromycin
Drug: Placebo

First Posted Date: 2017-08-14

Last Posted Date: 2022-07-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 756

Registration Number: NCT03248297

Locations: 🇨🇲
Cameroon Baptist Convention Health Services, Bamenda, Cameroon

Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas

Not Applicable

Completed

Conditions: Immature Arteriovenous Fistula

Interventions: Procedure: late Angioplasty
Procedure: early Angioplasty

First Posted Date: 2017-08-10

Last Posted Date: 2020-04-27

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 8

Registration Number: NCT03245944

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies

Phase 2

Completed

Conditions: Chronic Obstructive Pulmonary Disease
Emphysema

Interventions: Drug: Placebo
Biological: Belimumab

First Posted Date: 2017-08-09

Last Posted Date: 2023-07-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 17

Registration Number: NCT03244059

Locations: 🇺🇸
UAB Lung Health Center, Birmingham, Alabama, United States

Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome

Phase 2

Completed

Conditions: Ventilator-Induced Lung Injury
Preterm Infant
Respiratory Distress Syndrome
Bronchopulmonary Dysplasia

Interventions: Device: Mid frequency ventilation
Device: Standard frequency ventilation

First Posted Date: 2017-07-27

Last Posted Date: 2024-10-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT03231735

Locations: 🇺🇸
University of South Alabama, Mobile, Alabama, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Phase 2

Active, not recruiting

Conditions: Neurofibromatosis Type 1
Plexiform Neurofibroma

Interventions: Drug: Binimetinib

First Posted Date: 2017-07-27

Last Posted Date: 2023-12-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT03231306

Locations: 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

and more 19 locations

Mechanisms of Refractory Hypertension (Reserpine)

Phase 2

Completed

Conditions: Refractory Hypertension

Interventions: Drug: Reserpine

First Posted Date: 2017-07-21

Last Posted Date: 2021-11-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 7

Registration Number: NCT03223272

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: KRdD followed by auto-HCT
Drug: KRdD only

First Posted Date: 2017-07-21

Last Posted Date: 2023-11-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 123

Registration Number: NCT03224507

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy